---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-174803"
form_type: "8-K"
ticker: "NERV"
cik: "0001598646"
company_name: "Minerva Neurosciences, Inc."
filed_at: "2022-06-15T23:59:59+00:00"
generated_at: "2026-06-25T01:36:16.684610+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Minerva Neurosciences shareholders approve reverse stock split ratio of 1:4 to 1:10

## Summary
- Reverse stock split authorized by 93.5% of votes cast (25.9M for, 1.7M against).
- Three directors elected: Hilleman, Laghrissi-Thode, Luthringer (each with ~16M for).
- Advisory say-on-pay approved with 17.4M for, 891K against, 9.3M broker non-votes.
- Deloitte & Touche ratified as auditor for FY2022 with 27.1M for, 552K against.

## SEC filing metadata
- accession: 0001193125-22-174803
- form_type: 8-K
- ticker: NERV
- cik: 0001598646
- company_name: Minerva Neurosciences, Inc.
- filed_at: 2022-06-15T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1598646/000119312522174803/0001193125-22-174803-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1598646/000119312522174803/d315229d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-174803
- JSON: https://secwatch.observer/filing/0001193125-22-174803.json
- Plain text: https://secwatch.observer/filing/0001193125-22-174803.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.